endokrin askep hepatitis
TRANSCRIPT
-
8/17/2019 ENDOKRIN Askep Hepatitis
1/43
TUGAS
SISTEM ENDOKRIN
GANGGUAN PADA SISTEM HEPATIK
DISUSUN OLEH
KELOMPOK I :
ANDRI PURWO A (010830346B)
ERIK IRHAM L (010830419B)
HALIMATUS ZAHRA (010830415B)
JAJUK RETNOWATI (010830353B)
NURUL ROSIDAH (01083049B)
SEA TANDU LANGI (010830359B)
FAKULTAS KEPERAWATAN UNIVERSITAS AIRLANGGA
SURABAYA
2009
1
-
8/17/2019 ENDOKRIN Askep Hepatitis
2/43
BAB 1
PENDAHULUAN
1.1 Latar B!a"a#$
H!"#$%$%& '%& *!"#+#, %,-!+&% &%&$!*%+ ./! '%&'%& 2%&!$#% ,!+.&%& 2#,
%,-/#*#&% "#2# &!/&!/ #$% #, *!,#&%/+#, +*"/#, "!##, +/%,%& %.+%*%# &!$#
&!//! #, +#&7 S#*"#% #$ %,% &2# $!%
2!,$%-%+#&% $ $%"! !"#$%$%& '%& #, "#&$% !"#$%$%& A B : D E ; 2#, G7
!"#$%$%& A 2#, E *!*",#%
-
8/17/2019 ENDOKRIN Askep Hepatitis
3/43
"!,2%2%+#, +!&!#$#, #, !+!/#,$#, "!/#".#, &!$%#" +#&& !"#$%$%& '%& +!"#2#
D!"#$!*!, K!&!#$#, &!$!*"#$7
1.2 R%&%'a# Ma'a!a(
1. A"#+# *#
-
8/17/2019 ENDOKRIN Askep Hepatitis
4/43
BAB 2
TIN-AUAN PUSTAKA
2.1 Hat/t/'
H!"#$%$%& '%& *!"#+#, %,-!+&% &%&$!*%+ ./! '%& 2%&!$#% ,!+.&%& 2#, %,-/#*#&%
"#2# &!/&!/ #$% #, *!,#&%/+#, +*"/#, "!##, +/%,%& %.+%*%# &!$# &!//! #,
+#&7 S#*"#% #$ %,% &2# $!%2!,$%-%+#&% /%*# $%"! !"#$%$%& '%& #, "#&$% @ !"#$%$%& A B
: D E ; 2#, G &!$# !"#$%$%& $.+&%+ 2#, !"#$%$%& +#!,# .#$7 K!*2%#, #+%#$ 2#%
!"#$%$%& #2#/# &%.&%& !"#$%& !"#$.*# 2#, +.*# !"#$%
-
8/17/2019 ENDOKRIN Askep Hepatitis
5/43
2.1.1 Hat/t/' A
N#*# &!!/*,# H!"#$%$%& %,-!+&%.
P!,!#,# #2#/# '%& !"#$%$& A (HA)
:## "!,/##,,# *!/#/% #/ -!+#/.#/ ,%$#&% #, !/!+ +.,$#+ #,$#*#,&%#
2%#=# ./! #% 2#, *#+#,#, I,+#&%,# #2#/# 15 49 #% #$##$# 30 #%
I*,%$#& &!7 S$#$& +#%! $%2#+ $!2#"#$ $%2#+ 2%$!*+#, !"#$%$%&
+.,%& #, !+#%$#, 2!,#, !"#$%$%& A7
P!,/#, "#&%!,
• H%%!,! "!.#,#, #, #%+ 2!,#, *!,!+#,+#, +!%##, *!,
"!*#,#, /%*# #, #%+7
P!,
• #+&%, !"#$%$%& A 2%#,+#, ,$+ 2%!%+#, "#2#
17 P!,,, 2#!# #, *!,#/#*% "!,%,+#$#, "!,2!%$# !"#$%$%& A7
7 A,#+#,#+ #, $%,#/ 2% 2#!# !,2!*%+ !"#$%$%& A7
37 P!,2!%$# "!,#+%$ #$% +.,%+ 47 P!,2!%$# #,#, &%&$!* "!*!+#, 2## *%/,# !*."%/%
5
-
8/17/2019 ENDOKRIN Askep Hepatitis
6/43
57 P!7 S$#$& +#%! *,+%, $!#2%7 M!,%,+#$,# !&%+. !"#$%$%&
+.,%& &%.&%& 2#, +#,+! #$%7
P!,#$#/#+,##,
• T%# #%,
• N$%&% #, #2!+#$
• M# "!*/%#, +#2#,+#2#, *!*$+#, =#+$ 34 /#,
• P!$%*#,#, "&%+.&.&%#/ +!/## 2%%+$&!$#+#, 2#/#* "!!, "!,#+%$ $!&!$
P.,.&%&,# *.$#/%$#& &!+%$# 10 > &!"/ "!&!, "!,2!%$# !"#$%$%& B #+#,
*!,#/#*% !"#$%$%& +.,%&7 H!"#$%$%& B *!,#2% "!,!# $#*# &%.&%& 2#,
+#&%,.*# !"#$.&!//! 2% &!/ 2,%#7 P!,/#,
• :+" %&$%##$ 2#, *!,2#"#$ ,$%&% #, #%+
• B#% +!/## #$# !+#, "#&%!, 2%%,-.*#&%+#, ,$+ *!,2#"#$ '#+&%,
!"#$%$%& B #$# "!"##$ %*, /./%, !"#$%$%& B
P!,
• I*,%&% #+$%- #+&%, !"#$%$%& B ".$!+&% #, 2%#&%/+#, ./! '#+&%,
!"#$%$%& B 2#"#$ !/#,&, &!/#*# 5 $#, "!*!%+#, +#2# #,$%
HB& ,$+ *!,!,$+#, #"#+# 2%"!/+#, %*,%&% /#, #$# .&$!7
6
-
8/17/2019 ENDOKRIN Askep Hepatitis
7/43
• I*,%$#& "#&%- %*, /./%, !"#$%$%& B %,2%+#&% "!*!%#, "!"##$ %,%
,$+ .#, #, $!/# $!"##, HB $!$#"% !/* "!,# *!,2!%$# !"#$%$%&
B 2#, !/* "!,# *!,2#"#$+#, '#+&%, !"#$%$%& B7
2.1.3 Hat/t/' N#*# &!!/*,# !"#$%$%& ,.,A ,.,B7
P!,!#,# #2#/# '%& !"#$%$%& :
:## "!,/##,,# *!/#/% $#,&-&% 2## 2#, ".2+ 2## $!+!,# 2## #,
$!+.,$#*%,#&% /!=#$ "!#/#$#, #$# "##-!,#/%# .#$
M# %,+#&%,# #2#/# 15160 #% #$##$# 50 #%
I*,%$#& &!#,#, +!2# 2#"#$ .*./.& *!,,+#, %*,%$#& #, !,2# #$#
%,-!+&% ./! #!,& /#%,7
T#,2# 2#, !#/# &!"# 2!,#, HB $%2#+ !%$ !#$ 2#, #,%+$!%+7 S!%, $!#2%
&$#$& +#%! #, +.,%& 2#, "!,#+%$ #$% #, +.,%&7*!,%,+#$,# !&%+. +#,+!
#$%7
T!#"%,# #2#/# "!"##$ %,$!-!., 2!,#, %#'%%, &#$ #,#/. ,+/!.&%2# 2#,
"!*!%+#, &+%,%, !"#$%$%& : ,$+ $#,&-&% $!/# *!,#,% */# +#&&
!"#$%$%& #, !+#%$#, 2!,#, $#,&-&%7
2.1.4 Hat/t/' D
- P!,!#,# #2#/# '%& !"#$%$%& D (HD)7
- :## "!,/##,,# #2#/# *# &!"!$% HB7 A,$%!, "!*+##, HB 2%"!/+#,
,$+ !"/%+#&% "./# "!,/##, &!"# 2!,#, "./# "!,/##, !"#$%$%& B7
- I,+#&%,# #2#/# 1140 #% #$##$# 35 #%7
- I*,%$#&,# &!
#, #%+ 2#, +!%##, *!,
-
8/17/2019 ENDOKRIN Askep Hepatitis
8/43
- T!#"%,# #2#/# "!"##$ %*, /./%, 2#/#* *!*!%+#, "!/%,2,#, $!#2#"
'%& !"#$%$%& E !/* 2%+!$#%7
2.1.6 Hat/t/' F HFV
- P!,!# 2#% !"#$%$%& ; %,% %2%."#$%+ (!/* 2%+!$#%)
-G!#/#FT#,2#:
##, 2%$!*+#, "#2# *#,&%#7 B%/# #2# *%%" HAFHE7
- P!,!##, !"#$%$%& ; *!/#/% */$ (.#/) 2#, +.$.#,F$%,# (-!+#/)7
D#/#* #/ %,% #2# #/ #, "!/ 2%"!#$%+#,2#% H; #%$
17 H; *!"#+#, "#$%
8
-
8/17/2019 ENDOKRIN Askep Hepatitis
9/43
- H!"#$%$%& $.+&%+ #2#/# C#$C#$ +%*%# $!$!,$ *!*%/%+% !-!+ $.+&%+ "#2# #$% 2#,
2%!%+#, "! .#/ #$# "#!,$#/ 2#"#$ *!,%*/+#, ,!+.&%& &!/ #$% #, #+$7
- Z#$ #, "#/%, &!%, $!/%#$ 2#/#, +!/#%,#, %,% #2#/# +#., $!$#+/.%2# -.&-.
+/..-.* 2#, &!,#=# !*#&7 B#,#+ .#$ *!,%*/+#, !"#$%$%& *!&+%", /!%
!&%-#$ &!,&%$#&% +!$%*#, $.+&%+7 A+%#$,# #2#/# !"#$%$%& #, 2%$%*/+#, ./!
.#$ &!"# !"#$%$%& '%& #, #+$ *!&+%", 2!*%+%#, +!+#, "#!,+%* #$%
#,$%%.$%+ $!$!,$ #,$%*!$#./%$ 2#, .#$.#$ #,!$!&%7
- M#,%&-!&$#&% +/%,%+ #2#/# #,.!+&%# *#/ 2#, *,$# "#/%, &!%, 2%$!*+#,
%+$!& 2#, !"#$.*!#/%7 J%+# "## *#+# #+#, "#,#& !$#*# /!*# *,$#
!*#$!*!&%& +!/#%,#, "!*!+#, 2## !/#,&, !#$ &!%,# $#*"#+
"!2###, 2% #=# +/%$ +./#"& '#&+/! 2!/%%* +.*# +!#, #+#,
*!,%,#/7
- P!,#$#/#+,##,,# #2#/# *!*/%+#, 2#, *!*"!$##,+#, +!&!%*#,#,
-
8/17/2019 ENDOKRIN Askep Hepatitis
10/43
2.3.1 A6a t/$a t/ '/r4'/' ata% &7#t%"a# ar%t 6a!a& (at/ :
- irosis portal laennec (#/+../%+ ,$%&%.,#/)2%*#,# #%,#, "#$ &!
"!*!#, #$% #,
- H/rt#'/ 4rta!
T!+#,#, ".$#/ ,.*#/ !+% #,$## 510 **H7 H%"!$!,&% ".$#/ $%*/ #"#%/#
$!2#"#$ +!,#%+#, $!+#,#, 2#/#* &&$!* ".$#/ #, &%-#$,# *!,!$#" 2% #$#& ##
,.*#/7 D%&!$ %"!$!,&% ".$#/ %/# $!+#,#, ".$#/ /!% 2#% 0
-
8/17/2019 ENDOKRIN Askep Hepatitis
11/43
H%"!$!,&% ".$#/ $%*/ %/# *!+#,%&*! +.*"!,&% %,% $%2#+ &!#&% /#% #+%#$
*!,%,+#$,# &!
-
8/17/2019 ENDOKRIN Askep Hepatitis
12/43
$##,#, "!*/ 2## ".$#/ '#&.2%/#$#&% &"/#,+,%+ 2#, &%&$!*%+ &!$# "!##,
#,#$.*% '!,# !&."#& #%#, #=#7
M!&+%", "#$.!,!&%& $!#2%,# .!+#, !&."#& *"#% #$ %,% $!$#" !/*
!/#& #2# !!#"# -#
7 M!,%,+#$,# $!+#,#, %,$#'#%&!& 2#, $!+#,#, ".$#/7
37 M!,%,+#$,# $!+#,#, "#2# 2%,2%, '#%&!& #, 2%$#,2#% 2!,#, $%*/,# /#
+!*!##, "#2# "!*!%+#, !,2.&+."% $!$#*# "#2# '#%&!& #, !7
47 ;##/ #$% #, !/!+7
T!+#,#, ".$#/ #, $%,% &!#$ &!$!/# $!#2%,# "!2###, #$ %,% 2%#,#"
&!##% -#
- E6&a
12
-
8/17/2019 ENDOKRIN Askep Hepatitis
13/43
K.,&!,$#&% #/*%, "/#&*# *!,, &!%,# *!,#2% "!2%&".&%&% ,$+ $!#2%
!2!*#7 P.2+&% #/2.&$!., !/!%#, #+, *!,#+%#$+#, !$!,&% ,#$%* #% 2#,
2#, !+&+!&% +#/%* 7
-K4&a Hat/" A2#/# &#$ &%,2.* ,!."&%+%#$%+ #, 2%$#,2#% 2!,#, #2#,# "!##,
+!##, ",,#, %,$!/!+$#/ 2#, +!/#%,#, ,!./.%& #, *!,!$#% +!/#%,#,
"#!,+%* #$%7 P#$.!,!&%&,# #2#/# +.*# !"#$%< *!"#+#, +!/#%,#, #,
2%"!,#% ./! !##% -#
+#!,# *!$#./%&* .#$ #, *!,, #+%#$ +!+#, &!/&!/ #$% $!#2%
"!,%*,#, .#$ 2#, &!/#,$,# 2#"#$ *!,%,+#$+#, %,-/ .#$ +! 2#/#* .$#+
+#!,# *!,,,# %+#$#, .#$ 2!,#, "/#&*# ".$!%, &!$# "!,%,+#$#, &!,&%$%'%$#&
!&!"$. .$#+ $!#2#" .#$ #, &!
+.*# !"#$%+7
13
-
8/17/2019 ENDOKRIN Askep Hepatitis
14/43
A+%#$ +!+#, &!/&!/ "#!,+%* #$% ##,##, "!/%,2, #, 2%#$
2%#$% 2#, 2%/!"#& &!7
K.*# ".$.&%&$!*%+ "!#/#,#,,# $%2#+ ".!&%- &!%,# !#/#!#/#
,!."&%+%#$%+7
- P#%r%#a# &ta74!/'& 'tr4$#
P!,,#, *!$#./%&* !&$.!, ./! #$% #, + 2#"#$ *!,%*/+#,
%,!+.*#&$%# #$.-% $!&$%& +!.,$.+#, #*$ "%& "#2# /#+%/#+% 2#, +!$%2#+#$#,
#%2 "#2# =#,%$# 2% *"%, !#/# &"%2! ,!'% (#,%.*#$# &!"!$% /##/##) 2#,
!%$!*# "#/*#*7
2.3.3 P&r/"a'aa# D/a$#4't/"
P!*!%+#, !,C%* *!,,++#, +!+#, &!/ #$% #%$ +#2# #/+#/%
-.&-#$#&! AST (SGOT) 2#, ALT (SGPT) *!,%,+#$ 2#, +#2# +./%,!&$#&!
&!* 2#"#$ *!,,7
E&.-#.&+."% 2#"#$ *!,,++#, #2#,# '#%&!& !&."#&7
P!*!%+#, %/%, 2%/#++#, ,$+ *!,+ !+&+!&% !*"!2 #$#
!$!,&% !*"!27
A/*%, &!* *!,, +#!,# "!,!+#,#, &%,$!&%&7
G/./%, (I A 2#, I B) "!,%,+#$#, &%,$!&%&7
D## /!,+#" HFH$ 2#, SDM *,+%, *!,, +#!,# "!2###,7
M# ".$.*%,FPTT *!*#,#, ("!,,#, &%,$!&%& ".$.*%,)7
14
-
8/17/2019 ENDOKRIN Askep Hepatitis
15/43
A*.,%# &!* *!,%,+#$ +#!,# +!$%2#+*#*"#, ,$+ !# 2#%
#**.,%# *!,#2% !#7
G/+. &!* %"./%+!*%# 2%2# *!,#, /%+.!,!&%&7
E/!+$./%$ %".+#/!*%# *!,,++#, "!,%,+#$#, #/2.&$!., *!&+%",
+!$%2#+&!%*#,#, 2#"#$ $!#2%7
L#"##&+."% ,$+ %."&% *!*,+%,+#, #$% &!
-
8/17/2019 ENDOKRIN Askep Hepatitis
16/43
A+$%'%$#&F I&$%##$
G!#/# K!/!*##, +!/!/##, *#/#%&!7
T#,2# L!$#% "!,,#, *#& .$.$F$.,&7
S%+/#&%
G!#/# D%&%*%# ,% #,$, !+&$# (S3 S4)
T#,2# B#2%+#2% %+$!%+ "#2# &+!/!# +/%$ *!*#,! *+.
E/%*%,#&%
G!#/# ;/#$& %,! !/#" 2%#!F+.,&$%"#&%7
T#,2# D%&$!,&% #2.*!, (!"#$.*!#/% &"/!,.*!#/%#&%$!&) "!,,#, %&%,
-!&!& =#,# $#,# /%#$ *!/!,# %,! !/#" "!+#$7
M#+#,#,F :#%#,
G!#/# A,.!+&%# "!,,#, !#$ #2#, #$# *!,%,+#$ (!2!*#) *#/ *,$#
T#,2# P!,,#, !#$ #2#, #&%$!& +/%$ +!%, $. + %+$!%+ ,#"#&
!# "!2###, &%7
N!.&!,&.%
G!#/# "!,,#, *!,$#/
T#,2# P!+# #,, %,, #/&%,#&% %/!$#% 2#, +.*#7
N!%FK!,#*#,#,
G!#/# K#* #2.*!, ,!% $!+#, "#2# +#2#, #$#& #$#/%# +%$ +!"#/# #$#/
("%$&)7
T#,2# O$.$ $!#, !/% 2%&$#+&% -.
-
8/17/2019 ENDOKRIN Askep Hepatitis
17/43
• H#&%/ #, 2%##"+#, *!,#$#+#, "!*##*#, &%$#&% *!,,++#, "%/#+
*!/#++#, #+$%'%$#& 2#, "!,%,+#$#, #+$%'%$#&7
I,$!'!,&% 2#, #&%.,#/
B!%+#, /%,+,#, #, $!,#,
RF *!,!2%#+#, !,!% #, 2%,#+#, ,$+ "!,!*#,7 U# ".&%&% 2!,#, &!%,
RF *!,%,+#$#+, -,&% "!,#"#, 2#, *!*%,%*#/+#, $!+#,#, "#2# #!# $!$!,$
,$+ *!,,+#, !&%+. +!+#, #%,#,7
B#,$ /#$%#, !#+ "#&%-F#+$%-
RF $%# #%, /#*# *!,,+#, +!*#*"#, #, 2#"#$ *!,#, %&$%##$7
A#+#, $!+,%+ !/#+&%
RF *!,%,+#$+#, !/#+&% 2#, *!,%,+#$+#, +."%,7
K./#.#&% "!*!%#, .#$ #,$%#,&%!$#&7
RF *!*#,$ 2#/#* *#,#!*!, $%27
7 N$%&% +#, 2#% +!$#, $ !, 2!,#, %"!*!$#./%+ #,#,
#&.&% 2#, *!$#./%&*! "!,
• H#&%/ #, 2%##"+#, *!,%,+#$+#,F *!*"!$##,+#, !#$ #2#,
I,$!'!,&% 2#, #&%.,#/
B!% *#+#, &!2%+%$ $#"% &!%,
RF *#+#, #,#+ &/%$ *!,#$ %/# "#&%!, #,.!+&%#7
B!%+#, "!#=#$#, */$ #, &!%,
RF *!,%/#,+#, # $%2#+ !,#+ #, 2#"#$ *!,%,+#$+#, ,#-& *#+#,7
A,+#, *#+#, "#2# ".&%&% $!#+ RF *!,,+#, # "!, "#2# #2.*!, 2#, *!,%,+#$+#, ,#-& *#+#,
K./#.#&% 2!,#, #/% %C% ,$+ *!*!%+#, 2%!$ &!&#% +!$#, "#&%!,7
RF ,$+ *!*!,% +!$#, 2%!$ +/%!,7
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, #,$%!*!$%+ '%$#*%, 2#, #,$#&%2#
RF *!,,+#, *#/ *!,%,+#$+#, $./!#,&% "#2# *#+#,#, *!,,+#,
%%$#&%F!&%+. "!2###, 2#, *!*"!#%+% +!+#,#, 2#, *!*#,$ ".&!&
"!,!*#,7
37 R!&%+. './*!
-
8/17/2019 ENDOKRIN Askep Hepatitis
18/43
U+ $#,2#$#,2# '%$#/ "!,%&%#, +#"%/! $. +/%$ 2#, *!*#, *+.
RF %,2%+#$. './*! &%+/#&%
U+ /%,+# #2.*!, 2#, "!*!,$+#, !2!*# &!&#% %,2%+#&%7
RF *!,,+#, +!*,+%,#, "!2###, +! 2#/#* #%,#,
G,#+#, &"., 2#/#* "!*!&%#, */$ 2#, &%/#$ %%
RF *!,%,2#% $#*# 2#, "!2###, &% O&!'#&% $#,2# "!2###,
RF +#2# ".$.*%, *!,, 2#, =#+$ +.#/#&% *!*#,#, %/# #&.&% '%$#*%, K
$!#, "#2# $#+$& GI 2#, &%,$!&%&".$.*%, *!,, +#!,# *!*"!,#%
#$%7
K./#.#&% 2!,#, 2.+$! 2#, "!$#& /#.#$.%* ,$+ "!,#*%/#, 2#,
"!*!%#, HFH$ N# #/*%, 2#, =#+$ 2#/#* "!*!+#,
RF *!,,++#, %2#&% 2#, *!,%2!,$%-%+#&% !$!,&% ,#$%*F+#2# ".$!%, #,
2#"#$ *!,%*/+#, "!*!,$+#, !2!*#7
K./#.#&% 2!,#, 2.+$! 2#/#*
RF "!,.#$#, !"#$%$%& #+%#$ +.,%& "!,.#$#, !"#$%$%& #+$!%#/ 2#, *!,
*!*#$#&% %,-!+&% &!+,2!7
57 K!+#, %,$!%$#& +/%$ !,#, 2!,#, #+*/#&% ##* !*"!2 2#/#*
#%,#,7
• H#&%/ #, 2%##"+#, *!,,++#, "!#%+#, #%,#,F+/%$ "!,,#,
"%$&7
I,$!'!,&% 2#, #&%.,#/
A,+#, *#,2% #% 2%,%, #$#&% , &!=#+$ *#,2% 2#, /.$%.,
RF *!,
A,+#, *!,,#+#, ++ #% ,$+ *!,#+ %/# $%2#+ $!+.,$./7RF *!,,+#, ".$!,&%#/
18
-
8/17/2019 ENDOKRIN Askep Hepatitis
19/43
H%,2#% +.*!,$# $!,$#, "!,#*"%/#, "#&%!,
RF *!*%,%*#/+#, &$!& "&%+./%& &!,#, 2!,#, "!##, +/%$
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, $!#"% #,$%%&$#*%, 2#, #,$%/%"!*%+7
RF *!,%/#,+#, #$#/ 2#, *!,
0
: #+#/ 2%,%,$%2#+ *!,!/ #2#,
"#,#& #2#, $%2#+ +!%,#$#,
I,$!'!,&% 2#, #&%.,#/
- U+ & $ &!$%#" 4 #*
RF *!*#,$ 2#/#* 2%#,.&%&
- O&!'#&% & /%,+,#, +/%!,
RF ## & *!,2!+#$% ,.*#/
- B!% "#+#%#, #, $%"%&
RF *!*#,$ !'#".#&% &
- B!% +.*"!& #% #,#$ 2% %".$#/#*&
RF %".$#/#*& "$ !/#&% "#,#& &!%,# &!!# $, "#,#& +/%!, %/#
2%+.*"!& 2% %".$#/#*&7
- K./#.#&% 2#/#* "!*!%#, #,$%"%!$%+
RF .#$ ,$+ *!,,+#, "#,#& 2%*#,# 2%# !+!# 2% %".$#/#*& &!##% "$
!/#&% "#,#&
7 N!% #+$ !,#, 2!,#, ".&!& %,-/#*#&% %&+!*%# #%,#,F,!+.&%&
• H#&%/ #, 2%##"+#, +/%!, *!,#$#+#, ,!% %/#, &+#/# ,!% 13
*!,,++#, =## $%2#+ *!%,%&7
I,$!'!,&% 2#, #&%.,#/
- O&!'#&% 2#,
-
8/17/2019 ENDOKRIN Askep Hepatitis
20/43
• H#&%/ #, 2%##"+#, +.,&!,$#&% %/%, &!* 2#, .%/%,.!, %,
*!,, #/##, %, #, #2!+#$7
I,$!'!,&% 2#, #&%.,#/
- O&!'#&% #/%#, %,! 2#, -!+#/
RF *!,!$#% #/%#, %,! #2!+#$- O&!'#&% 2#,
-
8/17/2019 ENDOKRIN Askep Hepatitis
21/43
RF #/*%, ,$+ *!,%,+#$+#, $!+#,#, .&*.$%+ +./.%2 2#/#* +.*"#$!*!,
'#&+/! &!%,# *!,%,+#$+#, './*! &%+/#&% !-!+$%- 2#, "!,,#, #&%$!&7
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, .#$ 2%!$%+ +#/%* %,.$."%+ ".&%$%-
2#, '#&.2%/#$#&% #$!%#/RF *!,##$ !-!+ #/2.&$!., *!,%,+#$+#, !+&+!&% #% *!,!*#$ +#/%* +#/%*
&!* 2#, &!//! %#,# *!,, +#!,# "!,#+%$ #$% &!&#% 2!,#, +!%/#,#,
%,! *!,%,+#$+#,
-
8/17/2019 ENDOKRIN Askep Hepatitis
22/43
RF *!,%,+#$+#, "!,#*"%/#,
47 N$%&% +#, 2#% +!$#, $ !,#, 2!,#, %"!*!$#./%+ #,#,
#&.&% 2#, *!$#./%&*! "!,
•H#&%/ #, 2%##"+#, *!,%,+#$+#,F *!*"!$##,+#, !#$ #2#,
I,$!'!,&% 2#, #&%.,#/
B!% *#+#, &!2%+%$ $#"% &!%,
RF *#+#, #,#+ &/%$ *!,#$ %/# "#&%!, #,.!+&%#7
B!%+#, "!#=#$#, */$ #, &!%,
RF *!,%/#,+#, # $%2#+ !,#+ #, 2#"#$ *!,%,+#$+#, ,#-& *#+#,7
A,+#, *#+#, "#2# ".&%&% $!#+
RF *!,,+#, # "!, "#2# #2.*!, 2#, *!,%,+#$+#, ,#-& *#+#,
K./#.#&% 2!,#, #/% %C% ,$+ *!*!%+#, 2%!$ &!&#% +!$#, "#&%!,7
RF ,$+ *!*!,% +!$#, 2%!$ +/%!,7
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, #,$%!*!$%+ '%$#*%, 2#, #,$#&%2#
RF *!,,+#, *#/ *!,%,+#$+#, $./!#,&% "#2# *#+#,#, *!,,+#,
%%$#&%F!&%+. "!2###, 2#, *!*"!#%+% +!+#,#, 2#, *!*#,$ ".&!&
"!,!*#,7
57 K!+#, %,$!%$#& +/%$ !,#, 2!,#, #+*/#&% ##* !*"!2 2#/#*
#%,#,7
• H#&%/ #, 2%##"+#, *!,,++#, "!#%+#, #%,#,F+/%$ "!,,#,
"%$&7
I,$!'!,&% 2#, #&%.,#/
A,+#, *#,2% #% 2%,%, #$#&% , &!=#+$ *#,2% 2#, /.$%.,
RF *!,
A,+#, *!,,#+#, ++ #% ,$+ *!,#+ %/# $%2#+ $!+.,$./7
RF *!,,+#, ".$!,&%#/
H%,2#% +.*!,$# $!,$#, "!,#*"%/#, "#&%!,
RF *!*%,%*#/+#, &$!& "&%+./%& &!,#, 2!,#, "!##, +/%$
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, $!#"% #,$%%&$#*%, 2#, #,$%/%"!*%+7
RF *!,%/#,+#, #$#/ 2#, *!,
"!,,#, !+&"#,&% "# #+*/#&% &!+!$ +!/!*##, 2#, "!,,#, !,!%7
• H#&%/ #, 2%##"+#, *!*"!$##,+#, "./# ,#"#& !-!+$%- !#& 2%&",!# 2#,
&%#,.&%& 2!,#, ,%/#% GDA
I,$!'!,&% 2#, #&%.,#/
U+ -!+!,&% +!2#/#*#, 2#, "## "!,#"#,
RF "!,#"#, 2#,+#/
22
-
8/17/2019 ENDOKRIN Askep Hepatitis
23/43
O&!'#&% $%,+#$ +!##,
RF "!##, *!,$#/ 2#"#$ *!,,++#, %".+&!*%# ##/ ,#"#& 2#, +.*# !"#$%+7
B!% ".&%&% $!*"#$ $%2 #, $%,% 2!,#, +!"#/# *%%,
RF *!*2#+#, "!,#"#, 2!,#, *!,,+#, $!+#,#, "#2# 2%#-#*# 2#,
*!*%,%*#/+#, #&"%#&% &!+!$7 U# ".&%&% 2!,#, &!%,@ ##+#, ,#"#& 2#/#* 2#, /#$%#, #$+
RF *!*#,$ !+&"#,&% "# 2#, *.%/%&% &!+!$
U+ & &!&#% %,2%+#&%
RF *!,!$#% #2#,# %,-!+&%
K./#.#&% 2!,#, 2.+$! 2#, "!$#& /#.$#.%* 2#/#* "!,#*%/#, GDA
RF *!,#$#+#, "!##, &$#$& "!,#"#,
K./#.#&% 2!,#, 2.+$! 2#, "!$#& #2%./.%
RF *!,#$#+#, "!##, &$#$& "!,#"#,
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, .+&%!,
RF *!,.#$%F*!,
%,&!,$%- $%" #/.,
RF *!,,+#, #$!/!+$#&%& 7
7 P.$!,&%#/ +.*"/%+#&% "!2###, !,#, 2!,#, ".-%/ 2## #,.*#/
#,#, -#+$. "!*!+#, ("!,,#, ".2+&% ".$.*%, -%%,.!, 2#,
-#+$.III I @ #,#, #&."&% '%$#*%, K@ 2#, "!,!/#, $.*."/#&$%,)
%"!$!,&% ".$#/7
• H#&%/ #, 2%##"+#, *!*"!$##,+#, .*!.&$#&%& 2!,#, $#,"# "!2###,
2#, *!,,++#, "!%/#+ "!,,#, !&%+. "!2###,7
I,$!'!,&% 2#, #&%.,#/
O&!'#&% $#,2#$#,2# 2#, !#/#!#/# "!2###, GI
RF $#+$& GI (!&.-#& 2#, !+$*) *!"#+#, &*! "!2###, +#!,# *+.
#, *2# + 2#, #,#, 2#/#* !*.&$#&%& +#!,# &%.&%&7
U+ $#,2#$#,2# '%$#/ &!&#% %,2%+#&%
RF "!,%,+#$#, ,#2% 2#, "!,,#, $!,&% *!,,++#, +!%/#,#, './*! 2##
&%+/#&%
O&!'#&% $%,+#$ +!##,
RF "!##, 2#"#$ *!,,++#, "!,,#, "!-&% #%,#, &!!#/ &!+,2!
$!#2#" %".'./!*%# %".+&!*%#7
A,+#, *!*#+#% &%+#$ %% #/& "!,
-
8/17/2019 ENDOKRIN Askep Hepatitis
24/43
RF *!*%,%*#/+#, +!+#, #%,#, *!,,+#, !&%+. "!2###,
H%,2#+#, *!,,#+#, #&"%%,
RF +.#/#&% *!*#,#, !".$!,&% !&%+. "!2###,
K./#.#&% 2!,#, 2.+$! 2#, "!$#& /#.#$.%* 2#/#* "!,#*%/#, HFH$ 2#,
-#+$. "!*!+#,RF %,2%+#$. #,!*%# "!2###, #+$%-
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, '%$#*%, (K D :) 2#, "!/,#+ -!&!&
RF *!,%,+#$+#, &%,$!&%& ".$.*%, 2#, +.#/#&% %/# #$% !-,&% +!+#,#,
'%$#*%, : *!,%,+#$+#, +!!,$#,#, &%&$!* GI ,$+ %%$#&%F"!2###, 2#, *!,
*!,!#, #, #+%,# *!,%,+#$+#, $!+#,#, %,$# #2.*!, 2#, !&%+. .!+#,
'#&+/#F"!2###,
Hat4&a17 I,$./!#, A+$%'%$#& !,#, 2!,#, *!,#/#*% +!$!#$#, #+$%'%$#& "!,,#,
+!+#$#,7
• H#&%/ #, 2%##"+#, *!,#$#+#, "!*##*#, &%$#&% *!,,++#, "%/#+
*!/#++#, #+$%'%$#& 2#, "!,%,+#$#, #+$%'%$#&7
I,$!'!,&% 2#, #&%.,#/
B!%+#, /%,+,#, #, $!,#,
RF *!,!2%#+#, !,!% #, 2%,#+#, ,$+ "!,!*#,7
U# ".&%&% 2!,#, &!%,
RF *!,%,+#$#+, -,&% "!,#"#, 2#, *!*%,%*#/+#, $!+#,#, "#2# #!# $!$!,$
,$+ *!,,+#, !&%+. +!+#, #%,#,7
B#,$ /#$%#, !#+ "#&%-F#+$%-
RF $%# #%, /#*# *!,,+#, +!*#*"#, #, 2#"#$ *!,#, %&$%##$7
A#+#, $!+,%+ !/#+&%
RF *!,%,+#$+#, !/#+&% 2#, *!,%,+#$+#, +."%,7
K./#.#&% "!*!%#, .#$ #,$%#,&%!$#&7
RF *!*#,$ 2#/#* *#,#!*!, $%27
7 N$%&% +#, 2#% +!$#, $ !,#, 2!,#, %"!*!$#./%+ #,#,
#&.&% 2#, *!$#./%&*! "!,
• H#&%/ #, 2%##"+#, *!,%,+#$+#,F *!*"!$##,+#, !#$ #2#,
I,$!'!,&% 2#, #&%.,#/
B!% *#+#, &!2%+%$ $#"% &!%,
RF *#+#, #,#+ &/%$ *!,#$ %/# "#&%!, #,.!+&%#7
B!%+#, "!#=#$#, */$ #, &!%,
RF *!,%/#,+#, # $%2#+ !,#+ #, 2#"#$ *!,%,+#$+#, ,#-& *#+#,7
A,+#, *#+#, "#2# ".&%&% $!#+
RF *!,,+#, # "!, "#2# #2.*!, 2#, *!,%,+#$+#, ,#-& *#+#, K./#.#&% 2!,#, #/% %C% ,$+ *!*!%+#, 2%!$ &!&#% +!$#, "#&%!,7
24
-
8/17/2019 ENDOKRIN Askep Hepatitis
25/43
RF ,$+ *!*!,% +!$#, 2%!$ +/%!,7
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, #,$%!*!$%+ '%$#*%, 2#, #,$#&%2#
RF *!,,+#, *#/ *!,%,+#$+#, $./!#,&% "#2# *#+#,#, *!,,+#,
%%$#&%F!&%+. "!2###, 2#, *!*"!#%+% +!+#,#, 2#, *!*#,$ ".&!&
"!,!*#,7
37 G#,#, ## 2%% !,#, 2!,#, #,#, "!,#*"%/#, -%&%+
• H#&%/ #, 2%##"+#, *!,#$#+#, "!*##*#, #+#, "!##, 2#, "!,!%*##,
2%% "#2# &%$#&% #, #2# *!,!,#/ "!##, 2#, *!$.2! +."%, #, ".&%$%-
I,$!'!,&% 2#, #&%.,#/
D.., "!,#$##, # $#+$ !/#&+#, ,#, #,$## !#/# 2!,#, #/ "!,#+%$
RF "#&%!, ,#$ ".&%$%- $!#2#" "!##, $ 2#, *!,#/#*% "!##, !/#
%/# "!,!#,# #2#/# #/
-
8/17/2019 ENDOKRIN Askep Hepatitis
26/43
K./#.#&% 2!,#, 2.+$! 2#, "!$#& /#.$#.%* 2#/#* "!,#*%/#, 2#,
"!,,##, #/*%, &!* 2#, !/!+$./%$
RF "!,,#, #/*%, &!* *!*"!,#% $!+#,#, .&*.$%+ +./.%2 "/#&*#
*!,#+%#$+#, "!*!,$+#, !2!*#7 K./#.#&% 2!,#, 2.+$! 2#, "!$#& #2%./.% ,$+ -.$. 2#2#
RF *!/%#$ +.,!&$% '#&+/! !2!*# "# 2#, !-&% "/!#7
K./#.#&% 2!,#, 2.+$! 2#/#* "!*#$#, ,#$%* 2#,
RF *!,##$ !-!+ #/2.&$!., *!,%,+#$+#, !+&+!&% #% *!,!*#$ +#/%* +#/%*
&!* 2#, &!//! %#,# *!,, +#!,# "!,#+%$ #$% &!&#% 2!,#, +!%/#,#,
%,! *!,%,+#$+#,
U+ -!+!,&% +!2#/#*#, 2#, "## "!,#"#,
26
-
8/17/2019 ENDOKRIN Askep Hepatitis
27/43
RF "!,#"#, 2#,+#/
RF *!,!$#% #"#+# #2# +.*"/%+#&% 2#, !&%+. %,-!+&%
O&!'#&% $%,+#$ +!##,RF "!##, *!,$#/ 2#"#$ *!,,++#, %".+&!*%# ##/ ,#"#& 2#, +.*# !"#$%+7
B!% ".&%&% $!*"#$ $%2 #, $%,% 2!,#, +!"#/# *%%,
RF *!*2#+#, "!,#"#, 2!,#, *!,,+#, $!+#,#, "#2# 2%#-#*# 2#,
*!*%,%*#/+#, #&"%#&% &!+!$7
U# ".&%&% 2!,#, &!%,@ ##+#, ,#"#& 2#/#* 2#, /#$%#, #$+
RF *!*#,$ !+&"#,&% "# 2#, *.%/%&% &!+!$
U+ & &!&#% %,2%+#&%
RF *!,!$#% #2#,# %,-!+&%
K./#.#&% 2!,#, 2.+$! 2#, "!$#& /#.$#.%* 2#/#* "!,#*%/#, GDA
RF *!,#$#+#, "!##, &$#$& "!,#"#, K./#.#&% 2!,#, 2.+$! 2#, "!$#& #2%./.%
RF *!,#$#+#, "!##, &$#$& "!,#"#,
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, .+&%!,
RF *!,.#$%F*!,
%,&!,$%- $%" #/.,
RF *!,,+#, #$!/!+$#&%& 7
47 G#,#, ## 2%% !,#, 2!,#, #,#, "!,#*"%/#, -%&%+
• H#&%/ #, 2%##"+#, *!,#$#+#, "!*##*#, #+#, "!##, 2#, "!,!%*##,
2%% "#2# &%$#&% #, #2# *!,!,#/ "!##, 2#, *!$.2! +."%, #, ".&%$%-
I,$!'!,&% 2#, #&%.,#/
D.., "!,#$##, # $#+$ !/#&+#, ,#, #,$## !#/# 2!,#, #/ "!,#+%$
RF "#&%!, ,#$ ".&%$%- $!#2#" "!##, $ 2#, *!,#/#*% "!##, !/#
%/# "!,!#,# #2#/# #/
-
8/17/2019 ENDOKRIN Askep Hepatitis
28/43
17 N$%&% +#, 2#% +!$#, $ !,#, 2!,#, %"!*!$#./%+ #,#,
#&.&% 2#, *!$#./%&*! "!,
• H#&%/ #, 2%##"+#, *!,%,+#$+#,F *!*"!$##,+#, !#$ #2#,
I,$!'!,&% 2#, #&%.,#/
B!% *#+#, &!2%+%$ $#"% &!%,RF *#+#, #,#+ &/%$ *!,#$ %/# "#&%!, #,.!+&%#7
B!%+#, "!#=#$#, */$ #, &!%,
RF *!,%/#,+#, # $%2#+ !,#+ #, 2#"#$ *!,%,+#$+#, ,#-& *#+#,7
A,+#, *#+#, "#2# ".&%&% $!#+
RF *!,,+#, # "!, "#2# #2.*!, 2#, *!,%,+#$+#, ,#-& *#+#,
K./#.#&% 2!,#, #/% %C% ,$+ *!*!%+#, 2%!$ &!&#% +!$#, "#&%!,7
RF ,$+ *!*!,% +!$#, 2%!$ +/%!,7
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, #,$%!*!$%+ '%$#*%, 2#, #,$#&%2#
RF *!,,+#, *#/ *!,%,+#$+#, $./!#,&% "#2# *#+#,#, *!,,+#,
%%$#&%F!&%+. "!2###, 2#, *!*"!#%+% +!+#,#, 2#, *!*#,$ ".&!&
"!,!*#,7
E6&a
17 P!##, './*!
-
8/17/2019 ENDOKRIN Askep Hepatitis
29/43
RF *!*%,%*#/+#, !$!,&%
RF *!,##$ !-!+ #/2.&$!., *!,%,+#$+#, !+&+!&% #% *!,!*#$ +#/%* +#/%*
&!* 2#, &!//! %#,# *!,, +#!,# "!,#+%$ #$% &!&#% 2!,#, +!%/#,#,
%,! *!,%,+#$+#,
O&!'#&% $%,+#$ +!##,
RF *!,!$#% $%,+#$ +!##, +/%!,
K.,&/ "#2# .#, $!2!+#$ $!,$#, "!%/#+ ** 2#, *!,$#/ +/%!,
RF *!*!%+#, 2# ,$+ *"!#,2%,#, 2!,#, &$#$& #$ %,%
A,+#, "#&%!, *!,/%& ,#*#
RF $!& ,!./.%& &!2!#,# 2#, +..2%,#&% .$.$
O%!,$#&%+#, =#+$ $!*"#$ .#, $!2!+#$
RF *!*"!$##,+#, .%!,$#&% +!,#$##, B!% /%,+,#, #, ,#*#, 2#, $!,#,
29
-
8/17/2019 ENDOKRIN Askep Hepatitis
30/43
RF *!,,+#, #,,#, !/!%#, *!,%,#$+#, !/#+&% 2#, *!*"!$##,+#,
+."%,7
A,+#, "#&%!, $%# #%, &!/#*# "!#=#$#,
RF *!,,+#, +!$#, *!$#./%+ #$% *!,
P#, "!,#*#, $!*"#$ $%2 2#, !% #,$#/#,RF *!,,+#, !&%+.
U+ $#,2#$#,2# '%$#/
RF %,-!+&% 2#"#$ *!,
#, *!*"!,#% *!,$#/ $#,2# $!#2%,# !,&!-#/."#$% #$# *!,
&!"!$% #*.,%# !/!+$./%$ "H BUN /+. 2## /!,+#"
RF "!,%,+#$#, +#2# #*.,%# %".+#/!*%# #/+#/.&%& *!$#./%+ %"./%+!*%#
#,!*%# 2#, %,-!+&% *!,
RF #*.,%#*!,!#+#, !,&!-#/."#$% !"#$%+ +.,&$%"#&% 2#"#$ *!,%,+#$+#, +!#
#+$!% 2#, "!*!,$+#, #*.,%# ".$!%, ,##$% /!% #%+ 2#%"#2# ".$!%, !=#,%
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, !/!+$./%$ "!/!*$ -!&!& "!*!&%
+./., (
-
8/17/2019 ENDOKRIN Askep Hepatitis
31/43
O&!'#&% 2#,# !-/!+&!-/!+& $!$!,$
RF "!,,#, !-/! *!,#,2#+#, #2#,# +!+#, "#2# $%,+#$ .$#+ $!,# #$#
#$#, .$#+ 2#, !"!#, $!#2#" +!#*#,#, +/%!,7
H%,2#% 2#% +!%&%,#,
RF *!*!%+#, !-!+ +!$!,#,#, 2#, *!,%,+#$+#, %&$%##$7 A,+#, .#, $!2!+#$ ,$+ !%P#%r%#a# &ta74!/'& 'tr4$#
17 G#,#, ## 2%% !,#, 2!,#, #,#, "!,#*"%/#, -%&%+
• H#&%/ #, 2%##"+#, *!,#$#+#, "!*##*#, #+#, "!##, 2#, "!,!%*##,
2%% "#2# &%$#&% #, #2# *!,!,#/ "!##, 2#, *!$.2! +."%, #, ".&%$%-
I,$!'!,&% 2#, #&%.,#/
D.., "!,#$##, # $#+$ !/#&+#, ,#, #,$## !#/# 2!,#, #/ "!,#+%$
RF "#&%!, ,#$ ".&%$%- $!#2#" "!##, $ 2#, *!,#/#*% "!##, !/#
%/# "!,!#,# #2#/# #/
-
8/17/2019 ENDOKRIN Askep Hepatitis
32/43
TRIGGER ASE
1. PENGKA-IAN
B%.2#$#
N#*# T,7 M
U* 8 $#,B#, I,2.,!&%#
A#*# I&/#*
A/#*#$ S!"#,#, &%2.#.
P!+!##, ,#/%& (=#$#=#,)
MRS */#% $/ 18 *#!$ 009
P!,+#%#, $/ 19 *#!$ 009
D *!2%& S&"!
-
8/17/2019 ENDOKRIN Askep Hepatitis
33/43
T#,2# G:S 456 +!##, :.*".& *!,$%& &+/!# *#$# 2#, +/%$
$!/%#$ %+$!&7
47 B4 (B/#22!)
G!#/# +/%!, *!,#$#+#, *%,* 8 !/#&F#% %,!,# !=#,# ##+
!/#" !# -!+!,&% BAK 5F#% BAK 1 !/#&F#%7
T#,2# %,! !=#,# !/#" 2#, "!+#$ *%,* #% "$% 1800 */F4 #*
*/# %,! 1000 */F4 #*7
57 B5 (B.=!/)
G!#/# +/%!, *!,#$#+#, ,#-& *#+#, *!,, #2# *#/ 2#, $%2#+ #2#
*,$# *#+#, $%2#+ #%& 1 "%%, 2#, # &!%, *#+#, 2% "%,%
#/#,7T#,2# "#/"#&% !"# !"#$.*!#/% %,#,
-
8/17/2019 ENDOKRIN Askep Hepatitis
34/43
B%/%, %,2%!
U%,! N%/#% ,.*#/
G/+. 1 ()
B%/%%, 3 ()
"H 60 (343)
P.$!%, 3 ()
N%$.!, 1 () L!+.&%$ () ()
R.,$!,
T.#+ PA .,
-
8/17/2019 ENDOKRIN Askep Hepatitis
35/43
DATA ETIOLOGI MASALAH
S +/%!, *!,#$#+#, ,#-& *#+#,
*!,, #2# *#/ 2#, $%2#+ #2#
*,$# *#+#, $%2#+ #%& 1 "%%,
2#, # &!%, *#+#, 2% "%,%
#/#,7
O
P#/"#&% !"# !"#$.*!#/%
%,#, #2# ,!% $!+#, #$#&
-
8/17/2019 ENDOKRIN Askep Hepatitis
36/43
S +/%!, *!,#$#+#, *%,* 8
!/#&F#% %,!,# !=#,# ##+
!/#" !# -!+!,&% BAK
5F#% BAK 1 !/#&F#%7
O
!=#,# !/#" 2#, "!+#$7
*%,* #% "$% 1800 */F4
#*
*/# %,! 1000 */F4
#*7
H#&%/ UL
G/+. 1
B%/%%, 3
"H 60
P.$!%, 3
N%$.!, 1
L!+.&%$ ()
H#&%/ "!*!%+#, 2##
SGOT 146 UFL
SGPT 1386
UFL
B%/%, 2%!
-
8/17/2019 ENDOKRIN Askep Hepatitis
37/43
UFL
B%/%, 2%!
-
8/17/2019 ENDOKRIN Askep Hepatitis
38/43
11. PRIORITAS DIAGNOSA KEPERAWAN
#7 P.$!,&%#/ +.*"/%+#&% %,-!+&% !,#, 2!,#, "!$##,#, "%*! $%2#+
#2!+#$7
7 N$%&% +#, 2#% +!$#, $ !,#, 2!,#, "!$##,#, "%*!
$%2#+ #2!+#$ 2#, +#, "!,!$##, $!,$#, "!*##,#, "#$.!,7
-
8/17/2019 ENDOKRIN Askep Hepatitis
39/43
-7 G#,#, ## 2%% !,#, 2!,#, #,#, "!,#*"%/#, -%&%+
12. INTERVENSI KEPERAWATAN
17 P.$!,&%#/ +.*"/%+#&% %,-!+&% !,#, 2!,#, "!$##,#, "%*! $%2#+ #2!+#$
*#/,$%&% +#, "!,!$##, ,$+ *!,%,2#% "!*##,#, "#2# "#$.!,7
• T#, +!"!#=#$#, S!$!/# 2%/#++#, $%,2#+#, +!"!#=#$#, 2#/#* =#+$ 3
4 #* +/%!, *!,#$#+#,
P!*##*#, "!,!# "!,#+%$
M!,#,% -#+$. %,-!+&%
T#,2#$#,2# '%$#/ 2#/#* #$#& ,.*#/
I,$!'!,&% 2#, #&%.,#/
L#++#, $!+,%+ %&./#&% ,$+ %,-!+&%
RF *!,
RF ".$!,&%#/ !&%+. +.*"/%+#&% &!+,2!
J!/#&+#, ".&!2 %&./#&% "#2# "#&%!, 2#, .#, $!2!+#$
RF "!*##*#, #/#, ,$+ "!/%,2,#, 2%% *!!+# &!,2%% 2#, .#, /#%, 2#"#$
*!,#,% "!##, %&./#&% 2#, &$%*#7
B!%+#, %,-.*#&% *!,!,#% '#+&%, !"#$%$%&
RF !-!+$%- 2#/#* *!,
/!,+#" ,$+ &!$%#" #%,#7RF %,2%
• T#, &!$!/# 2%/#++#, $%,2#+#, +!"!#=#$#, +/%!, !*%,#$ $!#2#"
*#+#,#, 2#/#* =#+$ 3 4 #* 2!,#, +%$!%# #&%/
A2# ,#-& *#+#,
T%2#+ #2# *#/ 2#, *,$#
K/%!, *!,#%&+#, 1 ".&% *#+#,#,
I,$!'!,&% 2#, #&%.,#/
39
-
8/17/2019 ENDOKRIN Askep Hepatitis
40/43
- B!% *#+#, &!2%+%$ $#"% &!%,
RF *#+#, #,#+ &/%$ *!,#$ %/# "#&%!, #,.!+&%#7
- B!%+#, "!#=#$#, */$ #, &!%,
RF *!,%/#,+#, # $%2#+ !,#+ #, 2#"#$ *!,%,+#$+#, ,#-& *#+#,7
- A,+#, *#+#, "#2# ".&%&% $!#+
RF *!,,+#, # "!, "#2# #2.*!, 2#, *!,%,+#$+#, ,#-& *#+#,- B!% $!#"% 2%!$ !,%& H1 100 +#/ (TKTP)7
RF ,$+ *!*!,% +!$#, 2%!$ +/%!,7
- B!%+#, R#,%$%2%, 31 $#/!$F#%
RF *!,,+#, %%$#&%F!&%+. "!2###,
- B!%+#, %,-&! RD 1500 */F4 #*
RF *!,%,+#$+#, $./!#,&% "#2# *#+#,#,7
- B!%+#, */$%'%$#*%, 1 $#/!$F#%
RF *!,%,+#$+#, $./!#,&% "#2# *#+#,#,7
- K./#.#&% 2#/#* "!,#*%/#, #/*%, 2#, BUN &!$%#" #%,#7
RF %,2%
- A,+#, +/%!, #,#+ *%,* &!#,#+ 3 /%$!
RF *!*"!$##,+#, %2#&% 2#, #/%#, %,! #, #2!+#$
- A,+#, +/%!, *#+#, # +#$!& !2#, &!*#,+#
RF ,$+ *!*"!/#,
-
8/17/2019 ENDOKRIN Askep Hepatitis
41/43
RF *!*"!,#% #/%#, %,! 2#, %,$!%$#& #%,#,
47 I,$./!#,&% #+$%-%$#& -%&%+ !,#, 2!,#, +!$##,#, -%&%+ #, *!,,
•T#, +!"!#=#$#, S!$!/# 2%/#++#, $%,2#+#, +!"#!#=#$#, 2#/#* =#+$ 34
#* +/%!, 2%##"+#,
B#2#, $%2#+ /!*#&
A2# ,#-& *#+#,
M%,* 3 LF4 #*
B!#+$%-%$%$#& $#,"# #*#$#,
I,$!'!,&% +!"!#=#$#,
-B!%+#, /%,+,#, #, $!,#, RF *!,!2%#+#, !,!% #, 2%,#+#, ,$+ "!,!*#,7
-U# ".&%&% &!$%#" #*
RF *!,%,+#$+#, -,&% "!,#"#, 2#, *!*%,%*#/+#, $!+#,#, "#2# #!# $!$!,$
,$+ *!,,+#, !&%+. +!+#, #%,#,7
-B#,$ !2%% 2#, +! +#*# *#,2%
RF $%# #%, /#*# *!,,+#, +!*#*"#, #, 2#"#$ *!,#, %&$%##$7
-A,+#, +/%!, *!*#*!,2!,#+#, &%##, #2%. #, 2%&+#%
RF *!,%,+#$+#, !/#+&% 2#, *!,%,+#$+#, +."%,7
-K./#.#&% "!*!%#, .#$ #,$%#,&%!$#&7
RF *!*#,$ 2#/#* *#,#!*!, $%27
57 K!+#, %,$!%$#& +/%$ !,#, 2!,#, #+*/#&% ##* !*"!2 2#/#*
#%,#,7
• T#, +!"!#=#$#, &!$!/# 2%/#++#, $%,2#+#, +!"!#=#$#, 2#/#* =#+$ 34
#* +/%!, 2%##"+#,
M!,,++#, +/%$ #, $%2#+ %+$!%+
P!,,#, "%$&7 T!/%#$ ##, *!,#+ +/%$
I,$!'!,&% 2#, #&%.,#/
A,+#, *#,2% #% 2%,%, #$#&% , &!=#+$ *#,2% 2#, /.$%.,
RF *!,
A,+#, *!,,#+#, ++ #% ,$+ *!,#+ %/# $%2#+ $!+.,$./7
RF *!,,+#, ".$!,&%#/
H%,2#% +.*!,$# $!,$#, "!,#*"%/#, "#&%!,
RF *!*%,%*#/+#, &$!& "&%+./%& &!,#, 2!,#, "!##, +/%$
K./#.#&% 2!,#, 2.+$! 2#/#* "!*!%#, $!#"% #,$%%&$#*%, 2#, #,$%/%"!*%+7
RF *!,%/#,+#, #$#/ 2#, *!,
-
8/17/2019 ENDOKRIN Askep Hepatitis
42/43
• T#, +!"!#=#$#, &!$!/# 2%/#++#, $%,2#+#, +!"!#=#$#, 2#/#* =#+$ 4
#* +/%!, 2%##"+#,
M!,#$#+#, "!*##*#, #+#, "!##, #, $!#2%
P!,!%*##, 2%% "#2# &%$#&% #, #2#
M!,!,#/ "!##, 2#, *!$.2! +."%, #, ".&%$%- I,$!'!,&% 2#, #&%.,#/
D.., "!,#$##, # $#+$ !/#&+#, ,#, #,$## !#/# 2!,#, #/ "!,#+%$
RF "#&%!, ,#$ ".&%$%- $!#2#" "!##, $ 2#, *!,#/#*% "!##, !/#
%/# "!,!#,# #2#/# #/
-
8/17/2019 ENDOKRIN Askep Hepatitis
43/43
H!"#$%$%& '%& *!"#+#, %,-!+&% &%&$!*%+ ./! '%& 2%&!$#% ,!+.&%& 2#, %,-/#*#&% "#2#
&!/&!/ #$% #, *!,#&%/+#, +*"/#, "!##, +/%,%& %.+%*%# &!$# &!//! #, +#&7
S#*"#% #$ %,% &2# $!%2!,$%-%+#&% /%*# $%"! !"#$%$%& '%& #, "#&$% @ !"#$%$%& A B : D
E ; 2#, G &!$# !"#$%$%& $.+&%+ 2#, !"#$%$%& +#!,# .#$7 K!*2%#, #+%#$ 2#% !"#$%$%&
#2#/# &%.&%& !"#$%& !"#$.*# %"!$!,&% ".$#/ #&%$!& "!2###, GI T#
I,2.,!&%#7